Smith & Nephew to return up to $300m to shareholders in new strategy
16th Dec 2021 12:28
(Sharecast News) - Medical device maker Smith & Nephew outlined its new 'strategy for growth' on Thursday, targeting consistent 4% to 6% organic revenue growth by 2024, "structurally ahead" of historic levels, as it made a new commitment to return up to $300m of capital to shareholders.
Read moreSmith & Nephew hit by Delta variant and shortages
4th Nov 2021 07:36
(Sharecast News) - Smith & Nephew warned annual results would be at the low end of its guidance after Covid-19 and product shortages affected its orthopaedics business in the third quarter.
Read moreBerenberg lowers target price on Smith & Nephew
1st Oct 2021 10:54
(Sharecast News) - Analyst at Berenberg cut their target price on medical equipment manufacturer Smith & Nephew from £20.20 to £18.80 on Friday, stating the firm was now facing a "bumpier road" to the "same destination".
Read moreDirector dealings: SMith & Nephew chair ups stake
24th Aug 2021 16:21
(Sharecast News) - Smith & Nephew revealed on Tuesday that chairman Roberto Quarta had acquired 4,149 ordinary shares in the FTSE 100-listed medical equipment manufacturing company.
Read moreSmith & Nephew revenues surge in Q2
29th Jul 2021 08:50
(Sharecast News) - Manufacturing firm Smith & Nephew said on Thursday that revenues soared last quarter amid easing Covid-19 restrictions.
Read moreThursday broker round-up
1st Jul 2021 13:45
(Sharecast News) - Ascential: Berenberg upgrades to buy with a target price of 485p.
Read moreCredit Suisse highlights 'underappreciated growth drivers' at Smith & Nephew
9th Jun 2021 08:09
(Sharecast News) - Credit Suisse upgraded shares of artificial hip and knee maker Smith & Nephew on Wednesday to 'outperform' from 'neutral', lifting the price target to 1,805p from 1,560p as it pointed to "underappreciated growth drivers".
Read moreSmith & Nephew reinstates guidance as Q1 revenues rise
29th Apr 2021 07:31
(Sharecast News) - Medical products supplier Smith & Nephew reinstated full year guidance after a rise in first quarter revenues driven by increased surgery volumes, acquisitions and new products.
Read moreBerenberg lowers target price on Smith & Nephew
22nd Feb 2021 11:18
(Sharecast News) - Analysts at Berenberg lowered their target price on medical equipment manufacturer Smith & Nephew from £20.05 to £19.85 on Monday, stating the group had sacrificed today "for a better tomorrow".
Read moreSmith & Nephew says Covid impact to remain in H1 as profits fall
18th Feb 2021 07:04
(Sharecast News) - Medical products business Smith & Nephew warned the Covid-19 pandemic impact was likely to continue into the first half of 2021 with uncertainty on the timing of recovery, as it reported a sharp fall in full-year profit.
Read moreMonday broker round-up
11th Jan 2021 12:47
(Sharecast News) - Weir: Credit Suisse downgrades to neutral with a target price of 2,150p.
Read moreSmith & Nephew revenues to drop as more procedures postponed
11th Jan 2021 07:54
(Sharecast News) - Medical technology company Smith & Nephew said on Monday that it expects to report a 7% decline in fourth-quarter underlying revenue and a 12% drop in full-year revenues, as more medical procedures are postponed due to rising numbers of coronavirus infections.
Read moreTuesday broker round-up
1st Dec 2020 13:38
(Sharecast News) - Diageo: Deutsche Bank upgrades to buy with a target price of 3,900p.
Read moreFriday broker round-up
30th Oct 2020 13:40
(Sharecast News) - Royal Dutch Shell: Barclays upgrades to equal weight.
Read moreSmith & Nephew sales improve in Q3, US business returns to growth
29th Oct 2020 07:53
(Sharecast News) - Smith & Nephew reported a "significant improvement" in trading in the third quarter on Thursday as global levels of elective surgeries continued to recover following the initial hit from the Covid-19 pandemic, while its US business returned to growth.
Read more